Federal grants to New York R&D Center for Translational Medicine and Therapeutics, Inc.
New York R&D Center for Translational Medicine and Therapeutics, Inc. in New Rochelle, New York received $4.5 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Aging Research, with $4.2 million. In fiscal 2025 it was awarded $719,580.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$4.5 million
- Awards4
- Awarded in FY 2025$719,580
- Largest award$1.9 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $469,997 |
| FY 2022 | 2 | $1.5 million |
| FY 2023 | 1 | $568,966 |
| FY 2024 | 2 | $1.3 million |
| FY 2025 | 1 | $719,580 |
Programs that fund New York R&D Center for Translational Medicine and Therapeutics, Inc.
| Program | Awards | Amount |
|---|---|---|
| Aging Research | 3 | $4.2 million |
| Military Medical Research and Development | 1 | $343,126 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $4.2 million |
| Department of Defense | 1 | $343,126 |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Mirna drug for tendinopathy - project summary tendinopathy is a tendon disorder that is highly prevalent in the aged population. It is characterized by tendon deterioration that often leads to tendon rupture, and is associated with pain, swelling and impaired performance. There is currently no cure | Aging Research | September 23, 2022 | $1.9 million |
| Exosome drug for tendinopathy - project summary tendinopathy is an age-related tendon disorder characterized by tendon deterioration and is associated with pain, swelling and impaired performance, and often leads to tendon rupture. Given that there is no disease- modifying therapeutic on the market, | Aging Research | June 20, 2024 | $1.5 million |
| A novel product for tendinopathy treatment | Aging Research | February 16, 2021 | $837,991 |
| A novel microrna-based strategy for the repair of injured tendons | Military Medical Research and Development | May 9, 2022 | $725,000 |
Questions people ask
How much federal grant money does New York R&D Center for Translational Medicine and Therapeutics, Inc. get?
$4.5 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives New York R&D Center for Translational Medicine and Therapeutics, Inc. the most?
The Department of Health and Human Services, with $4.2 million in 3 awards. The Department of Defense follow.
What is New York R&D Center for Translational Medicine and Therapeutics, Inc.'s largest federal grant?
$1.9 million under Aging Research, with its first action in the period on September 23, 2022. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund New York R&D Center for Translational Medicine and Therapeutics, Inc.?
Its largest are Aging Research and Military Medical Research and Development.
Other grant recipients in New Rochelle
- Iona University
- Urban Mining Industries, LLC
- City of New Rochelle
- Program of Academic Exchange, P.A.X.
- Silverbills Inc
- New Rochelle Municipal Housing Authority
- Salesian Missions, Inc.
- City School District of New Rochelle
Largest federal grant recipients in New York · Federal grants in New York